An unbiased, data-driven approach to CAR development
We leverage big data analytics and our global infrastructure to develop CAR-T therapies that are rooted in science and unbiased by previous work. We search for the best CAR constructs for a given indication, guided by analytics, as opposed to building off entrenched assumptions or licensing from academia. This allows us the freedom to innovate and the opportunity to take intellectual risks.
Monitoring Darwinian evolution through molecular genetics to find the best CARs
Our infrastructure, data transfer platform, and analytics capabilities allow us to cast a wider net to find the best CAR candidates; instead of choosing from five or ten constructs, we use multiple forms of directed molecular evolution to deliver the optimal CAB-CAR compositions from thousands of options.